Part 4: Interaction between unproven cellular therapies and global medicinal product approval regulatory frameworks.
Nichols K, Janssen W, Wall D, Cuende N, Griffin D. Part 4: Interaction between unproven cellular therapies and global medicinal product approval regulatory frameworks. Cytotherapy. 2016 Jan; 18(1):127-37.